SCHEMBL4298540

SCHEMBL4298540

C[C@@H]1NCCn2cc(-c3c(F)cc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)cc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.55
KCNH2 Q12809 4/20 0.55
ALDH1A1 P00352 4/20 0.55
HPGD P15428 4/20 0.55
HSD17B10 Q99714 3/20 0.55
POLB P06746 1/20 0.55
PRKD3 O94806 1/20 0.55
ALOX15 P16050 1/20 0.55
OPRM1 P35372 1/20 0.55
CLK2 P49760 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
TOP2A P11388 7/20 0.48
TOP2B Q02880 7/20 0.48
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 2/20 0.43
GSK3B P49841 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4293984 0.91 KDM4E (0.63) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL4293986 0.91 KDM4E (0.63) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL4305711 0.91 KDM4E (0.63) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL4304018 0.87 KCNH2 (0.49) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL4302229 0.87 KCNH2 (0.49) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL4297669 0.87 KCNH2 (0.49) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL13666573 0.85 TOP2A (0.49) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL7007548 0.82 TOP2A (0.53) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL7011115 0.81 TOP2A (0.54) KDM4EKCNH2ALDH1A1HPGDHSD17B10
SCHEMBL7005683 0.80 TOP2A (0.51) KDM4EKCNH2ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US claimed
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-29 US disclosed
WO-2009131973-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA NV (BE) 2009-10-29 WO disclosed
WO-2009131973-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA NV (BE) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270379-A1 QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS NQO2, QARS1, NQO1 KDM4E 2817/4885KCNH2 3433/4885ALDH1A1 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.